Vesalius Biocapital offers venture capital
to young European innovative life science companies

logo
Portfolio News

Pluriomics

Pluriomics focusses on the development of fully functional human assay systems for use in drug discovery and development. Based on their novel proprietary methods for differentiation of stem cells, the company develops highly functional cell types like the Pluricyte Cardiomyocytes which are used in combination with phenotypic assays to deliver high quality results.

http://www.pluriomics.com

Cell therapy

Netherland

Investing phase